Effexor Has 87 Percent Profit Margin
A very interesting bit from a very smart financial analyst who went and somehow figured out which drugs had the largest pre-tax profit margins. Topping the list was Effexor with an 87 percent pre-tax profit margin. Even more astonishing is that more than half of the drugs the analyst looked at had pre-tax margins of 70 percent or greater.
Here’s the list via Pharmalot:
1 – Effexor (Pfizer) 87 percent
2 – Arimidex (AstraZeneca) 85 percent
3 – Femara (Novartis) 84 percent
4 – Detrol (Pfizer) 84 percent
5 – Gemzar (Lilly) 84 percent
6 – Xeloda (Roche) 82 percent
7 – Lipitor (Pfizer) 82 percent
8 – Zometa (Novartis) 81 percent
9 – Plavix (Bristol-Myers/Sanofi-Aventis) 81 percent*
10 – Taxotere (Sanofi-Aventis) 80 percent
* – for the total brand, ignoring profit splits
Related posts:
- AP Reports Health Insurance Company Profits Not Very High
- Women Commits Suicide By OD’ing On Celexa, Effexor
- Iraq, Afghanistan Vets Get Mental Health Diagnoses At 37 Percent Rate
- Kids Non-Profit Head Slams Overmedicating Of Kids
- Study: 50 Percent Of Docs Don’t Know Indications Drugs Are Approved For